Cargando…

Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics

Less than half of severe asthmatic patients show a >80% adherence rate to inhaled treatment just before and during biologic therapy. This has implications in biologic treatment sustainability and disease prevalence estimation. http://bit.ly/3cRTJB0

Detalles Bibliográficos
Autores principales: Caminati, Marco, Vianello, Andrea, Andretta, Margherita, Menti, Anna Michela, Tognella, Silvia, Degli Esposti, Luca, Micheletto, Claudio, Bovo, Chiara, Senna, Gianenrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184111/
https://www.ncbi.nlm.nih.gov/pubmed/32363204
http://dx.doi.org/10.1183/23120541.00017-2020
_version_ 1783526553488982016
author Caminati, Marco
Vianello, Andrea
Andretta, Margherita
Menti, Anna Michela
Tognella, Silvia
Degli Esposti, Luca
Micheletto, Claudio
Bovo, Chiara
Senna, Gianenrico
author_facet Caminati, Marco
Vianello, Andrea
Andretta, Margherita
Menti, Anna Michela
Tognella, Silvia
Degli Esposti, Luca
Micheletto, Claudio
Bovo, Chiara
Senna, Gianenrico
author_sort Caminati, Marco
collection PubMed
description Less than half of severe asthmatic patients show a >80% adherence rate to inhaled treatment just before and during biologic therapy. This has implications in biologic treatment sustainability and disease prevalence estimation. http://bit.ly/3cRTJB0
format Online
Article
Text
id pubmed-7184111
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-71841112020-05-01 Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics Caminati, Marco Vianello, Andrea Andretta, Margherita Menti, Anna Michela Tognella, Silvia Degli Esposti, Luca Micheletto, Claudio Bovo, Chiara Senna, Gianenrico ERJ Open Res Original Research Letters Less than half of severe asthmatic patients show a >80% adherence rate to inhaled treatment just before and during biologic therapy. This has implications in biologic treatment sustainability and disease prevalence estimation. http://bit.ly/3cRTJB0 European Respiratory Society 2020-04-27 /pmc/articles/PMC7184111/ /pubmed/32363204 http://dx.doi.org/10.1183/23120541.00017-2020 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Original Research Letters
Caminati, Marco
Vianello, Andrea
Andretta, Margherita
Menti, Anna Michela
Tognella, Silvia
Degli Esposti, Luca
Micheletto, Claudio
Bovo, Chiara
Senna, Gianenrico
Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
title Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
title_full Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
title_fullStr Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
title_full_unstemmed Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
title_short Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
title_sort low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
topic Original Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184111/
https://www.ncbi.nlm.nih.gov/pubmed/32363204
http://dx.doi.org/10.1183/23120541.00017-2020
work_keys_str_mv AT caminatimarco lowadherencetoinhaledcorticosteroidslongactingb2agonistsandbiologictreatmentinsevereasthmatics
AT vianelloandrea lowadherencetoinhaledcorticosteroidslongactingb2agonistsandbiologictreatmentinsevereasthmatics
AT andrettamargherita lowadherencetoinhaledcorticosteroidslongactingb2agonistsandbiologictreatmentinsevereasthmatics
AT mentiannamichela lowadherencetoinhaledcorticosteroidslongactingb2agonistsandbiologictreatmentinsevereasthmatics
AT tognellasilvia lowadherencetoinhaledcorticosteroidslongactingb2agonistsandbiologictreatmentinsevereasthmatics
AT degliespostiluca lowadherencetoinhaledcorticosteroidslongactingb2agonistsandbiologictreatmentinsevereasthmatics
AT michelettoclaudio lowadherencetoinhaledcorticosteroidslongactingb2agonistsandbiologictreatmentinsevereasthmatics
AT bovochiara lowadherencetoinhaledcorticosteroidslongactingb2agonistsandbiologictreatmentinsevereasthmatics
AT sennagianenrico lowadherencetoinhaledcorticosteroidslongactingb2agonistsandbiologictreatmentinsevereasthmatics